3 Lead and Aluminium Recycler, Mid Income Housing and Senior Living Developer and Specialty Drug Maker Stocks With a Strong Future Roadmap: Gravita India, Ashiana Housing and Ajanta Pharma
- November 6, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Gravita India, Ashiana Housing and Ajanta Pharma: ROE of 13.6% to 23.3% and FY22 to FY26 revenue CAGR of 12.9% to 50.2%. Prices as of 5 Nov 2026.
Quick Answer
The three metal recycling, senior housing and drug stocks to watch are Gravita India, Ashiana Housing and Ajanta Pharma. Their return on equity ranges from 13.6% to 23.3%, and their revenue compound annual growth from FY22 to FY26 ranges from 12.9% to 50.2%. Ajanta Pharma has the highest return on equity at 23.3%, while Ashiana Housing has the fastest revenue growth at 50.2% a year. Prices are based on the 5 November 2026 close, and this article is educational, not investment advice.
Metal recycling, senior housing and drug stocks give investors a way to track businesses that sit close to everyday demand in India. Gravita India, Ashiana Housing and Ajanta Pharma cover a lead and aluminium recycler, a mid income housing developer and a specialty drug maker.
This list covers three metal recycling, senior housing and drug stocks with complete current figures: Gravita India, Ashiana Housing and Ajanta Pharma. Every figure comes from the latest reported financials and the 5 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Metal Recycling, Senior Housing and Drug Stocks?
Metal recycling, senior housing and drug stocks are listed companies that recycle lead, aluminium and plastic, develop mid-income residential projects and senior living communities, and sell branded generics in India and many emerging markets. Their earnings depend on metal demand, home sales and prescriptions.
Metal Recycling, Senior Housing and Drug Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Gravita India | 1,494.9 | 10,050 | 25.7 | 11.3 | 15.4 | 0.30 |
| Ashiana Housing | 348.05 | 3,586 | 30.3 | 30.7 | 13.6 | 0.35 |
| Ajanta Pharma | 3,282.1 | 41,241 | 36.3 | 36.0 | 23.3 | 0.06 |
On valuation, Ashiana Housing trades at a P/E below the industry P/E, while Gravita India and Ajanta Pharma trade above it, which reflects the growth the market already expects. Readers comparing metal recycling, senior housing and drug stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do Metal Recycling, Senior Housing and Drug Stocks Have a Strong Roadmap in India?
Metal recycling, senior housing and drug stocks have a strong roadmap in India because growing circular economy needs, rising mid-income housing demand and steady demand for branded medicines keep widening the market for these companies.
- Recycling. Industry needs steady secondary metal supply.
- Housing. Mid income families seek new homes.
- Specialty drugs. Doctors prescribe trusted brands.
Why Gravita India Features Among These Metal Recycling, Senior Housing and Drug Stocks
Among the metal recycling, senior housing and drug stocks on this list, Gravita India is a Jaipur-based recycler of lead, aluminium and plastic that operates plants in India, Africa and other regions and sells recycled metal products.
The company has a return on equity of 15.4%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 10,050 crore. The stock trades at a P/E of 25.7, above the industry P/E of 11.3.
Revenue rose from Rs 2,224 crore in FY22 to Rs 4,342 crore in FY26, a compound annual growth rate of 18.2%. Net profit grew from Rs 148 crore in FY22 to Rs 378 crore in FY26, which works out to a compound annual growth rate of 26.3%. In the June 2026 quarter, revenue grew 42.3% year on year to Rs 1,523 crore, while net profit rose 14.3% to Rs 106 crore.
Roadmap: The company is expanding recycling capacity and moving into value-added products, helped by rising focus on circular economy and recycled materials. A global sourcing network supports supply.
What to watch: Track capacity additions, volume growth and the share of value-added products.
Why Ashiana Housing Features Among These Metal Recycling, Senior Housing and Drug Stocks
Among the recycling, real estate and pharma shares on this list, Ashiana Housing develops mid-income residential projects and senior living communities in cities such as the Delhi region, Jaipur and Chennai. It is known for its focus on construction quality and timely delivery.
Revenue rose from Rs 234 crore in FY22 to Rs 1,187 crore in FY26, a compound annual growth rate of 50.2%. Net profit grew from Rs 27.9 crore in FY23 to Rs 118 crore in FY26, which works out to a compound annual growth rate of 61.7%.
The company has a return on equity of 13.6%, a debt to equity ratio of 0.35 and a market capitalisation of Rs 3,586 crore. The stock trades at a P/E of 30.3, below the industry P/E of 30.7.
Roadmap: The company is launching new phases in established markets and growing its senior living portfolio. A reputation for delivery supports sales in its projects.
What to watch: Track sales bookings, project launches and deliveries.
Why Ajanta Pharma Features Among These Metal Recycling, Senior Housing and Drug Stocks
Among the three companies on this list, Ajanta Pharma is a specialty pharmaceutical company that sells branded generics in India and in emerging markets across Asia and Africa, with a focus on ophthalmology, dermatology, cardiology and pain management, and also sells generics in the United States.
In the June 2026 quarter, revenue grew 27.7% year on year to Rs 1,697 crore, while net profit rose 30.9% to Rs 334 crore. Revenue rose from Rs 3,457 crore in FY22 to Rs 5,625 crore in FY26, a compound annual growth rate of 12.9%.
Net profit grew from Rs 713 crore in FY22 to Rs 1,056 crore in FY26, which works out to a compound annual growth rate of 10.3%. The company has a return on equity of 23.3%, a debt to equity ratio of 0.06 and a market capitalisation of Rs 41,241 crore. The stock trades at a P/E of 36.3, above the industry P/E of 36.0.
Roadmap: The company concentrates on niche therapies where it holds leading positions and has a wide field force in India and Africa. A steady flow of new launches and a debt-free balance sheet support expansion in branded markets.
What to watch: Monitor the pace of new launches in branded markets and the momentum in the United States generics business.
Gravita India vs Ashiana Housing vs Ajanta Pharma on Key Financials
The table below sets the three metal recycling, senior housing and drug stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Gravita India | 2,224 | 4,342 | 18.2% | 378 | 8.7% |
| Ashiana Housing | 234 | 1,187 | 50.2% | 118 | 9.9% |
| Ajanta Pharma | 3,457 | 5,625 | 12.9% | 1,056 | 18.8% |
Ajanta Pharma posts the highest return on equity in this group at 23.3%. Ajanta Pharma has the largest FY26 revenue at Rs 5,625 crore, and Ashiana Housing shows the fastest revenue growth with a 50.2% compound annual rate. A useful habit with metal recycling, senior housing and drug stocks is to check each new quarterly result against the capacity plans the company described earlier.
Key Risks to Check Before Investing in Metal Recycling, Senior Housing and Drug Stocks
Every theme carries risks that deserve a check before any decision. For these metal recycling, senior housing and drug stocks, the main points are: Long-term recycling, real estate and pharma shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Commodity prices. Selling prices follow global and domestic markets.
- Housing cycles. Real estate and building demand can vary with rates and sentiment.
- Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter metal recycling, senior housing and drug stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Metal Recycling, Senior Housing and Drug Stocks
Metal recycling, senior housing and drug stocks work best when investors track growth, valuation and return on equity side by side. Gravita India, Ashiana Housing and Ajanta Pharma each have a clear plan to grow. Based on the 5 November 2026 close, Gravita India trades at Rs 1,494.9, Ashiana Housing at Rs 348.05 and Ajanta Pharma at Rs 3,282.1. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these metal recycling, senior housing and drug stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track metal recycling, senior housing and drug stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are metal recycling, senior housing and drug stocks?
Ans. Metal recycling, senior housing and drug stocks are listed companies that recycle lead, aluminium and plastic, develop mid-income residential projects and senior living communities, and sell branded generics in India and many emerging markets. Their earnings depend on metal demand, home sales and prescriptions. This list looks at three of them, Gravita India, Ashiana Housing and Ajanta Pharma, using reported FY22 to FY26 financials and the 5 November 2026 closing prices.
Which metal recycling, senior housing and drug stocks are covered in this list?
Ans. This list covers Gravita India, Ashiana Housing and Ajanta Pharma. Based on the 5 November 2026 close, Gravita India traded at Rs 1,494.9, Ashiana Housing at Rs 348.05 and Ajanta Pharma at Rs 3,282.1. Their return on equity ranges from 13.6% to 23.3%, and their revenue compound annual growth from FY22 to FY26 ranges from 12.9% to 50.2%.
Why do metal recycling, senior housing and drug stocks have a strong future roadmap in India?
Ans. Metal recycling, senior housing and drug stocks have a strong roadmap in India because growing circular economy needs, rising mid-income housing demand and steady demand for branded medicines keep widening the market for these companies. The main drivers are as follows. Recycling. Industry needs steady secondary metal supply. Housing. Mid income families seek new homes. Specialty drugs. Doctors prescribe trusted brands. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Gravita India performed financially?
Ans. Revenue rose from Rs 2,224 crore in FY22 to Rs 4,342 crore in FY26, a compound annual growth rate of 18.2%. Net profit grew from Rs 148 crore in FY22 to Rs 378 crore in FY26, which works out to a compound annual growth rate of 26.3%. In the June 2026 quarter, revenue grew 42.3% year on year to Rs 1,523 crore, while net profit rose 14.3% to Rs 106 crore. The company has a return on equity of 15.4%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 10,050 crore. The stock trades at a P/E of 25.7, above the industry P/E of 11.3. Looking ahead, the company is expanding recycling capacity and moving into value-added products, helped by rising focus on circular economy and recycled materials. A global sourcing network supports supply.
How has Ashiana Housing performed financially?
Ans. Revenue rose from Rs 234 crore in FY22 to Rs 1,187 crore in FY26, a compound annual growth rate of 50.2%. Net profit grew from Rs 27.9 crore in FY23 to Rs 118 crore in FY26, which works out to a compound annual growth rate of 61.7%. The company has a return on equity of 13.6%, a debt to equity ratio of 0.35 and a market capitalisation of Rs 3,586 crore. The stock trades at a P/E of 30.3, below the industry P/E of 30.7. Looking ahead, the company is launching new phases in established markets and growing its senior living portfolio. A reputation for delivery supports sales in its projects.
How has Ajanta Pharma performed financially?
Ans. Revenue rose from Rs 3,457 crore in FY22 to Rs 5,625 crore in FY26, a compound annual growth rate of 12.9%. Net profit grew from Rs 713 crore in FY22 to Rs 1,056 crore in FY26, which works out to a compound annual growth rate of 10.3%. In the June 2026 quarter, revenue grew 27.7% year on year to Rs 1,697 crore, while net profit rose 30.9% to Rs 334 crore. The company has a return on equity of 23.3%, a debt to equity ratio of 0.06 and a market capitalisation of Rs 41,241 crore. The stock trades at a P/E of 36.3, above the industry P/E of 36.0. Looking ahead, the company concentrates on niche therapies where it holds leading positions and has a wide field force in India and Africa. A steady flow of new launches and a debt-free balance sheet support expansion in branded markets.
What risks should investors check before buying metal recycling, senior housing and drug stocks?
Ans. Investors should check a few risks before buying metal recycling, senior housing and drug stocks. Commodity prices. Selling prices follow global and domestic markets. Housing cycles. Real estate and building demand can vary with rates and sentiment. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of metal recycling, senior housing and drug stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 5 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
